Clearmind Medicine Starts First Human Trial for CMND-100
Ticker: CMND · Form: 6-K · Filed: Mar 18, 2025 · CIK: 1892500
| Field | Detail |
|---|---|
| Company | Clearmind Medicine INC. (CMND) |
| Form Type | 6-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | medium |
| Sentiment | bullish |
Sentiment: bullish
Topics: clinical-trial, drug-development, biotech
TL;DR
Clearmind Medicine just kicked off its first human trial for CMND-100 in alcohol use disorder patients. Big step!
AI Summary
Clearmind Medicine Inc. announced on March 18, 2025, the initiation of its first-in-human clinical trial for CMND-100, targeting patients with Alcohol Use Disorder. This marks a significant step in the company's development of novel treatments for psychiatric conditions.
Why It Matters
This trial represents a critical milestone for Clearmind Medicine, moving their potential treatment for Alcohol Use Disorder from preclinical to human testing, which could lead to new therapeutic options.
Risk Assessment
Risk Level: medium — Clinical trials are inherently risky, with a high probability of failure, and the success of CMND-100 is not guaranteed.
Key Players & Entities
- Clearmind Medicine Inc. (company) — Filer of the 6-K report and developer of CMND-100
- CMND-100 (drug_candidate) — The investigational drug being tested in the clinical trial
- Alcohol Use Disorder (medical_condition) — The condition being targeted by the CMND-100 clinical trial
- March 18, 2025 (date) — Date of the press release announcing the trial initiation
FAQ
What is the primary purpose of the Form 6-K filing?
The Form 6-K filing incorporates by reference a press release issued by Clearmind Medicine Inc. on March 18, 2025, announcing the initiation of its first-in-human clinical trial for CMND-100.
What is the name of the drug candidate Clearmind Medicine is testing?
The drug candidate being tested is named CMND-100.
What medical condition is CMND-100 intended to treat?
CMND-100 is intended to treat Alcohol Use Disorder.
When was the press release announcing the clinical trial filed?
The press release was filed on March 18, 2025.
What type of clinical trial is this for CMND-100?
This is the first-in-human clinical trial for CMND-100.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 18, 2025 regarding Clearmind Medicine Inc. (CMND).